ArticleFrontiers in cellular and infection microbiology2026
Evaluation of electroacupuncture acupoint selection's potential in the treatment of inflammatory bowel disease: an investigation using a mouse gut microbiome and metabolomics model.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electroacupuncture (EA) serves as an effective complementary therapy in the treatment of inflammatory bowel disease (IBD) within traditional Chinese medicine, with the therapeutic efficacy significantly influenced by the selection of specific acupoints. However, the regulatory mechanisms by which certain acupoints exhibit therapeutic benefits in IBD remain poorly understood. The research project intends to explore the mechanisms of action and regulatory variations in the treatment of IBD by the points Dachangshu (BL25), Tianshu (ST25), and Shangjuxu (ST37). This study used a sodium dextran sulfate-induced IBD mouse model to assess the therapeutic efficacy of three acupoints by evaluating body weight, colon morphology, inflammatory cytokines, gut microbiota, and metabolites. The results indicate that electroacupuncture of these three acupoints did not significantly alter IL-1β levels, but all three acupoints reduced IL-6 levels, with the most significant reduction observed at the Dachangshu acupoint. Furthermore, electroacupuncture treatment improved the structural characteristics of intestinal tissue and slowed the rate of weight loss. In IBD mice, electroacupuncture of three acupoints was associated with significant alterations in the intestinal microbiota and metabolic pathways. The majority of the metabolic pathways involved by these three acupoints are related to lipid, amino acid, and energy metabolism. Additionally, different acupuncture stimulation points also exhibited their own unique metabolic characteristics. These findings provide preliminary correlative evidence for the clinical application of acupuncture point selection in the treatment of IBD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.